Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 99 of 105, showing 5 Applications out of 523 total, starting on record 491, ending on 495

# Protocol No Study Title Investigator(s) & Site(s)

491.

ECCT/12/04/03   SELECT (SEcond-Line Effective Combination Therapy)
    A5273: Multicenter Study of Options for SEcond-Line Effective Combination Therapy (SELECT)   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
Moi University Clinical Research Centre
 
View

492.

ECCT/12/04/02   Short-course RPT/INH for latent TB in HIV-infected individuals
    A5279: Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection       
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
View

493.

ECCT/12/04/01  
    A double-masked randomised placebo-controlled trial of adjuvant topical 5-fluorouracil (5FU) treatment following surgical excision of ocular surface squamous neoplasia.       
Principal Investigator(s)
1. Stephen Gichuhi
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. PCEA Kikuyu Eye Unit (Kiambu county)
3. Sabatia Eye Hospital (Kakamega county)
4. Kitale District Hospital, Eye Unit (Trans Nzoia county)
5. Homa Bay District Hospital, Eye Unit (Homa Bay county)
 
View

494.

ECCT/12/03/01  
    Role of Fish Oil Omega-3 Fatty Acids on Depression among HIV-Seropositive Pregnant Women in Nairobi: A Randomized Double-blind Controlled Trial   
Principal Investigator(s)
1. Rose Okoyo Opiyo
Site(s) in Kenya
1. Riruta Health Centre (Nairobi City county)
2. Kariobangi North Health Centre (Nairobi City county)
3. Mathare North Health Centre (Nairobi City county)
4. Kayole II Sub-district hospital (Nairobi City county)
 
View

495.

ECCT/12/02/02   HIV/HPV-Adolescent Study
    Immunogenicity and Safety of quadrivalent human Papillomavirus Vaccine in HIV-Infected pre-adolescent girls and boys in Kenya.   
Principal Investigator(s)
1. Dr. Nelly Rwamba Mugo
Site(s) in Kenya
Thika
 
View